Någård, Mats
Ah-See, Mei-Lin
So, Karen
Vermunt, Marit
Thistlethwaite, Fiona
Labots, Mariette
Roxburgh, Patricia
Ravaud, Alain
Campone, Mario
Valkenburg-van Iersel, Liselot
Ottesen, Lone
Li, Yan
Mugundu, Ganesh http://orcid.org/0000-0002-3736-1884
Funding for this research was provided by:
AstraZeneca
Article History
Received: 17 February 2020
Accepted: 8 June 2020
First Online: 16 June 2020
Compliance with ethical standards
:
: M Labots, A Ravaud, L Valkenburg-van Iersel and M Vermunt have nothing to disclose in relation to this study. M-L Ah-See, L Ottesen and K So are employees and shareholders of AstraZeneca UK Limited. Y Li, G Mugundu and M Någård are employees and shareholders of AstraZeneca US Limited. M Campone has participated in advisory boards (fees paid to institution) for Abbvie, Accord, AstraZeneca, Novartis, Pfizer, Sandoz, Sanofi and (personal fees paid) for G1 Therapeutics and Lilly, acted as a consultant (fees paid to institution) for Novartis, Pierre Fabre Oncology, Sanofi and Servier, is a member of a speaker bureau (personal fees paid) for Lilly and Novartis, and has received travel reimbursement from AstraZeneca, Novartis, Pfizer and Roche. P Roxburgh has received honoraria from AstraZeneca and travel reimbursement and research funding from AstraZeneca and Tesaro. F Thistlethwaite has consultancy agreements with Novartis, Pfizer, Bristol-Myers Squibb, Achilles Therapeutics, GlaxoSmithKline, Kite and Gilead.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The institutional review board at each study center approved the protocol, and the study was conducted in accordance with the principles expressed in the Declaration of Helsinki, Good Clinical Practice, applicable regulatory requirements and the AstraZeneca policy on bioethics [CitationRef removed].
: All patients provided written informed consent prior to enrollment.